Summary

This episode covers the latest in biotech, market trends, and space innovation, featuring expert insights on peptides, new drug approvals, and SpaceX's upcoming IPO. Stay informed on cutting-edge health treatments, market strategies, and space tech developments.

Chapters

00:00 Tech Troubles and Market Outlook

00:39 FDA Approves Eli Lilly's Oral GLP-1 Medication

01:06 Introduction to Zurf and K-Beauty Trends

01:44 Understanding Peptides: Myths and Realities

02:38 Popular Peptides and Their Uses

04:05 Peptides Approved for Specific Indications

05:08 Common Peptides in Beauty and Fitness

06:08 Joe Rogan and the Peptide Recovery Trend

07:07 The Wild West of Peptide Market

08:30 Safety and Regulation of Peptides

10:22 Peptides and Cancer Risks

11:17 Stem Cell Treatments Abroad

12:11 Copper Peptides for Skin and Hair

13:42 Market Volatility and Investment Strategies

15:52 Oil Prices, Geopolitics, and Market Impact

17:31 Energy Stocks and Long-term Investment

20:26 Market Reactions to Tech and Telecom Stocks

33:32 Eli Lilly's Oral GLP-1: A Game Changer

36:04 Potential of SpaceX's IPO and Valuation

43:12 SpaceX's AI Data Centers in Space

45:07 Elon Musk and SpaceX's Future Visions

46:52 The Big Picture: Space, Waste, and Innovation

Host descriptions:

Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.

Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.

Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.

If you would like to join our email list, please reach out to contactgettinsavvy@gmail.com and let us know.